IntrinsicIntrinsic

Other Events ·

On August 28, 2026, Creative Medical Technology Holdings, Inc. stockholders approved an amendment to increase…

CELZCreative Medical Technology Holdings, Inc.

On August 28, 2026, Creative Medical Technology Holdings, Inc. stockholders approved an amendment to increase authorized common shares from 25 million to 100 million and the full exercise of investor warrants for 5,580,680 shares. The share increase proposal passed with 2,488,537 votes in favor against 595,527, while warrant approval received 678,541 votes for and 344,460 against. Creative Medical Technology Holdings operates in the medical technology sector, focusing on minimally invasive treatments for chronic pain.

More from Creative Medical Technology Holdings, Inc.

Explore CELZ